WCN24-2699 ANTIPROTEINURIC EFFECT OF SPIRONOLACTONE IN KIDNEY TRANSPLANT RECIPIENTS DURING A 5-YEAR FOLLOW-UP

WCN24-2699 ANTIPROTEINURIC EFFECT OF SPIRONOLACTONE IN KIDNEY TRANSPLANT RECIPIENTS DURING A 5-YEAR FOLLOW-UP

Saved in:

Bibliographic Details
Main Authors:	João Antônio Pessoa de Freitas, Marcos Vinicius de Sousa, Marilda Mazzali
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924015183
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-2149 POST-TRANSPLANT DIABETES MELLITUS: RISK FACTORS AND OUTCOMES IN A 5-YEAR FOLLOW-UP
by: Marcos Vinicius de Sousa, et al.
Published: (2024-04-01)

WCN25-661 Switching Strategies: Evaluating the Safety and Efficacy of Non-Steroidal Mineralocorticoid Antagonists (ns MRA) in Spironolactone- non tolerant Post-Transplant Recipients
by: Chakradhar Arepalli, et al.
Published: (2025-02-01)

WCN24-2518 VITAMIN B COMPLEX IN KIDNEY TRANSPLANT RECIPIENTS
by: I.S.R.A.E.L. RIVAS, et al.
Published: (2024-04-01)

WCN24-863 HISTOPLASMA ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN KIDNEY TRANSPLANT RECIPIENT
by: Walaa Dabbas, et al.
Published: (2024-04-01)

WCN24-1499 TACROLIMUS-INDUCED HYPOMAGNESEMIA IN A KIDNEY TRANSPLANT RECIPIENT
by: Wanprapit Noree, et al.
Published: (2024-04-01)

Is the Antiproteinuric Effect of Cyclosporine A Independent of Its Immunosuppressive Function in T Cells?
by: Bin Zhang, et al.
Published: (2012-01-01)

WCN24-2600 Tuberculosis in pediatric kidney transplant recipients: 35 years of experience
by: Vanesa Fauda, et al.
Published: (2024-04-01)

WCN24-165 IMPACT OF COVID-19 PANDEMIC ON MANAGEMENT OF PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
by: Mohamad Bassam Said
Published: (2024-04-01)

WCN24-845 THE RISK FACTORS OF COVID-19 ADVERSE OUTCOME AND FOLLOW-UP TWO-YEAR SURVIVAL RATE IN THE KIDNEY TRANSPLANT RECIPIENTS
by: Eugene Zeltyn-Abramov, et al.
Published: (2024-04-01)

WCN24-1470 EVOLUTION OF KIDNEY FUNCTION AT 24 MONTHS IN KIDNEY TRANSPLANT RECIPIENTS WITH A HISTORY OF COVID-19
by: Ruben Schiavelli, et al.
Published: (2024-04-01)

WCN24-1078 ENDOTHELIAL BIOMARKERS AS PREDICTORS OF MORTALITY FOLLOWING SARS-COV-2 INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS
by: Vanessa Alaíde Andrade do Vale, et al.
Published: (2024-04-01)

WCN24-1671 THE METABOLIC VULNERABILITY INDEX, REFLECTING MALNUTRITION AND INFLAMMATION, PREDICTS MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS
by: Sebastián Fuenzalida, et al.
Published: (2024-04-01)

WCN24-909 ARTERIAL HYPERTENSION (AH) IN RENAL TRANSPLANT RECIPIENTS (RT) RISK FACTORS AND INPACT
by: Ndiaga Sow, et al.
Published: (2024-04-01)

WCN24-2570 CRYPTOCOCCOSIS IN KIDNEY TRANSPLANT RECIPIENTS BETWEEN 1988-2023, PREVALENCE AND CLINIC CHARACTERISTIC
by: Lucas Ramos, et al.
Published: (2024-04-01)

Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR
by: H. Trimarchi, et al.
Published: (2014-01-01)

WCN24-1495 RELATIONSHIP BETWEEN LIVING-DONOR KIDNEY VOLUME AND RECIPIENT BODY WEIGHT RATIO ON OUTCOME OF KIDNEY TRANSPLANT RECIPIENT PATIENTS
by: Ye Min Hein, et al.
Published: (2024-04-01)

WCN24-1875 Central Blood Pressure Monitoring in Pediatric Kidney Transplant Recipients: A Comprehensive Evaluation
by: Paula Coccia, et al.
Published: (2024-04-01)

WCN24-2548 SHORT-TERM OUTCOMES WITH NO TAPERING TACROLIMUS TO BELATACEPT CONVERSION IN RENAL TRANSPLANT RECIPIENTS (RTRs)
by: Adela Mattiazzi, et al.
Published: (2024-04-01)

WCN24-772 COMPARATIVE ANALYSIS OF THE COVID-19 COURSE IN THE KIDNEY TRANSPLANT RECIPIENTS DURING DIFFERENT EPIDEMIOLOGICAL PERIODS
by: Kirill Komissarov, et al.
Published: (2024-04-01)

WCN24-1881 Interventions to improve life participation in kidney transplant recipients: a systematic review and meta-analysis
by: Anastasia Hughes, et al.
Published: (2024-04-01)

WCN24-2096 Fabry disease screening in male kidney transplant recipients. Two centers study from Argentina
by: Silvia Di Pietrantonio, et al.
Published: (2024-04-01)

WCN24-1131 OUTCOMES OF LIVE RELATED RENAL TRANSPLANT RECIPIENTS WITH THE USAGE OF ATLG VS BASILIXIMAB AS AN INDUCTION AGENT
by: Ruchir Dave, et al.
Published: (2024-04-01)

WCN24-671 ASSOCIATION BETWEEN BLOOD MYCOPHENOLIC ACID LEVEL AND GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS IN EARLY POST-TRANSPLANT PERIOD
by: Aung Khin Sint, et al.
Published: (2024-04-01)

WCN24-1823 DESENSITIZATION THERAPY IN HYPERIMMUNIZED LIVING DONOR KIDNEY TRANSPLANT RECIPIENTS AND ITS IMPACT ON GRAFT FUNCTION AND ACUTE REJECTION RATE IN THE FIRST YEAR POST-TRANSPLANT
by: Hugo Leonardo Reynoso de la Torre, et al.
Published: (2024-04-01)

WCN25-4518 STUDY OF DYSLIPIDEMIA IN KIDNEY TRANSPLANT RECIPIENTS
by: siddhavinayak rajmane, et al.
Published: (2025-02-01)

WCN25-3301 Flozination in kidney transplant recipients: is it safe?
by: Kristin George, et al.
Published: (2025-02-01)

WCN24-1028 IMPACT OF HEMODIALYSIS ACCESS ON EARLY POST-TRANSPLANT OUTCOMES AMONG LIVE-RELATED RENAL ALLOGRAFT RECIPIENTS
by: D.H.A.R.S.H.A.N. RANGASWAMY, et al.
Published: (2024-04-01)

The Effect of Early Spironolactone Administration on 2-Year Acute Graft Rejection in Cardiac Transplant Patients
by: Dragos-Florin Baba, et al.
Published: (2025-05-01)

Model-Informed Dose Optimization of Spironolactone in Neonates and Infants
by: Amira Soliman, et al.
Published: (2025-03-01)

WCN24-675 ACUTE DIARRHEA IN LIVING KIDNEY TRANSPLANT RECIPIENTS IN EARLY POST-TRANSPLANT PERIOD AT TWO TRANSPLANT CENTERS IN MYANMAR: ANY RELATION WITH BLOOD TACROLIMUS LEVEL?
by: Sai Aik Hla, et al.
Published: (2024-04-01)

WCN25-4438 JC VIRUS IS UNDERESTIMATED IN KIDNEY TRANSPLANT RECIPIENTS
by: Mirha Pjanic, et al.
Published: (2025-02-01)

WCN24-20 KIDNEY RE-TRANSPLANTATION IN CHILDREN
by: Mohamad Bassam Said
Published: (2024-04-01)

WCN24-448 KIDNEY TRANSPLANTS IN RECIPIENTS WITH A HISTORY OF CANCER, WE SHOULD DO MORE FOR THEM: A REVIEW OF SRTR DATA
by: Horacio Adrogue, et al.
Published: (2024-04-01)

WCN24-2398 TRALI, A RARE CASE SCENARIO IN POST TRANSPLANT KIDNEY RECIPIENT OF A TERTIARY CARE HOSPITAL IN EASTERN INDIA
by: S.I.D.D.H.A.R.T.H.A. SATAPATHY, et al.
Published: (2024-04-01)

The laboratory of lung function in the follow-up of lung transplant recipients
by: José Alberto Neder, et al.
Published: (2025-03-01)

WCN24-1533 ONE-YEAR OUTPATIENT FOLLOW-UP OF AKI SURVIVORS
by: Rodrigo Ramalho, et al.
Published: (2024-04-01)

WCN24-2632 IS TELEMEDICINE AN OPPORTUNITY TO INCREASE TRANSPLANT CANDIDATES ?
by: Franklin Barcellos, et al.
Published: (2024-04-01)

WCN24-1043 FRAILTY PHENOTYPE AMONG KIDNEY TRANSPLANT CANDIDATES: PREVALENCE AND ASSOCIATED FACTORS
by: Raoni de Oliveira Domingues da Silva, et al.
Published: (2024-04-01)

WCN24-2277 PERI-TRANSPLANT DESENSITIZATION WITH APHERESIS AND RITUXIMAB IN KIDNEY TRANSPLANT RECIPIENTS WITH PREFORMED DONOR-SPECIFIC ANTIBODIES AND A NEGATIVE CDC CROSSMATCH. A SINGLE EXPERIENCE CENTRE
by: C.I.N.T.H.I.A. C.A.R.O.L.I.N.A. B.A.L.D.A.L.L.O. MORENO, et al.
Published: (2024-04-01)

Evaluation of Trypanosoma cruzi parasitic load by real-time PCR and blood culture in long-term kidney transplant recipients
by: Juliana Jesus Guimarães Ferreira, et al.
Published: (2021-11-01)